Critical Group
ABR bacteria pathogens that are significantly difficult to treat, cause a substantial disease burden (mortality and morbidity), show increasing trends in resistance, are uniquely difficult to prevent, are highly transmissible and for which there are few potential treatments in the development pipeline. Although they may not be critical globally, pathogens in this category could be critical for some populations and specific geographical areas.